EUVIMEDEUVIMED entdecken
Crossref

Antioxidant properties of Trifolium resupinatum and its therapeutic potential for Alzheimer’s disease

Shayan Mardi, Zahra Salemi, Mohammad-Reza Palizvan

Folia Neuropathologica · 2023 · 61 (1) · 37-46

DOI: 10.5114/fn.2023.125599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Neuropathologica, 2023. Verfasst von Shayan Mardi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Arak University of Medical Sciences, Iran. Hauptthemen laut MEDLINE: Alzheimer Disease, Trifolium, Neuroprotective Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Alzheimer's disease (AD) is the most common cause of dementia and is characterized by a progressive deterioration in cognitive function, which typically begins with impairment in memory. Persian clover (Trifolium resupinatum) is an annual plant found in central Asia. Due to its contents (high flavonoid and isoflavones), extensive researches have been done on its therapeutic properties, such as multiple sclerosis (MS) treatment. In this study, we investigate the neuroprotective effects of this plant on Streptozotocin (STZ)-induced AD in rats. MATERIAL AND METHODS: This research aimed to evaluate the neuroprotective effect of Trifolium resupinatum on the spatial learning and memory, superoxide dismutase (SOD), expressions of β amyloid 1-42 (Ab 1-42 ), and b amyloid 1-40 (Ab 1-40 ) in the hippocampus of STZ-induced Alzheimer rats. RESULTS: Our data showed that Trifolium resupinatum extract administration for two weeks before and one week after AD induction significantly improves maze escape latency ( p = 0.027, 0.001 and 0.02 in 100, 200, and 300 mg of the extract, respectively) and maze retention time ( p = 0.003, 0.04 and 0.001 in 100, 200, and 300 mg of the extract, respectively). Also, the administration of this extract significantly increases the SOD levels from 1.72+0.20 to 2.31+0.45 ( p = 0.009), 2.48+0.32 ( p = 0.001) and 2.33+0.32 ( p = 0.007) and decreases the expressions of Ab 1-42 ) ( p = 0.001 in all concentrations of the extract) and Ab 1-40 ) ( p = 0.001 in all concentrations of the extract) in the rat's hippocampus. CONCLUSIONS: This study suggests that the alcoholic extract of Trifolium resupinatum has anti-Alzheimer and neuroprotective effects on rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseTrifoliumNeuroprotective AgentsRatsAnimalsAntioxidantsAmyloid beta-PeptidesPlant ExtractsHippocampusSuperoxide DismutaseDisease Models, AnimalMaze Learning

Stichwörter der Autor:innen

SODTrifolium resupinatumamyloid peptidespatial memoryAlzheimer's disease

Substanzen

AntioxidantsNeuroprotective AgentsAmyloid beta-PeptidesPlant ExtractsSuperoxide Dismutase

Autor:innen und Institutionen

  • Arak University of Medical Sciences, Iran.

Zitieren

APA

Mardi, S., Salemi, Z., & Palizvan, M. R. (2023). Antioxidant properties of Trifolium resupinatum and its therapeutic potential for Alzheimer’s disease. Folia Neuropathologica, 61(1), 37-46. https://doi.org/10.5114/fn.2023.125599

Vancouver

Mardi S, Salemi Z, Palizvan MR. Antioxidant properties of Trifolium resupinatum and its therapeutic potential for Alzheimer’s disease. Folia Neuropathologica. 2023;61(1):37-46. doi:10.5114/fn.2023.125599

BibTeX
@article{Mardi2023,
  author = {Mardi, Shayan and Salemi, Zahra and Palizvan, Mohammad-Reza},
  title = {Antioxidant properties of Trifolium resupinatum and its therapeutic potential for Alzheimer’s disease},
  journal = {Folia Neuropathologica},
  year = {2023},
  volume = {61},
  number = {1},
  pages = {37--46},
  doi = {10.5114/fn.2023.125599}
}
Kostenlos starten →